| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/07/2001 | EP0815139B1 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 11/07/2001 | EP0783693B1 In vitro models of cns function and dysfunction |
| 11/07/2001 | EP0777478B1 Inhibitors of rotamase enzyme activity |
| 11/07/2001 | EP0765152B1 Stimulation of hair growth by peptide-copper complexes |
| 11/07/2001 | EP0758452B1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 11/07/2001 | EP0755265B1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure |
| 11/07/2001 | EP0726772B1 A method for sensitization of cancer cells for killer cell mediated lysis |
| 11/07/2001 | EP0702560B1 Immunologic enhancement with intermittent interleukin-2 therapy |
| 11/07/2001 | EP0689596B1 Stimulation of immune response by viral protein |
| 11/07/2001 | EP0651768B1 USE OF p97 IN THE DIAGNOSIS OF ALZHEIMER DISEASE |
| 11/07/2001 | EP0546108B1 Pro-drugs for cck antagonists |
| 11/07/2001 | CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene |
| 11/07/2001 | CN1321167A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of HLA |
| 11/07/2001 | CN1321148A Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use |
| 11/07/2001 | CN1321093A Method to enhance and confine expression of genes |
| 11/07/2001 | CN1321091A Method of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 11/07/2001 | CN1321089A Methods and compositions for increasing intestinal absorption of fats |
| 11/07/2001 | CN1321082A Micronised pharmaceutical compositions |
| 11/07/2001 | CN1321080A Fast dissolving orally consumable films |
| 11/07/2001 | CN1320702A Polypeptide-human ATP-dependent serine proteinase 79 and polynucleotide for coding it |
| 11/07/2001 | CN1320701A Polypeptide-human protein 11 containing signalase I characteristic sequence fragment and polynucleotide for coding it |
| 11/07/2001 | CN1320700A Polypeptide-human ATP-dependent serine proteinase 15 and polynucleotide for coding it |
| 11/07/2001 | CN1320699A Polypeptide-human phosphatidase 9 and polynucleotide for coding it |
| 11/07/2001 | CN1320697A Polypeptide-human protein 11 containing site-specific recombinase characteristic sequence fragment and polynucleotide for coding it |
| 11/07/2001 | CN1320696A Polypeptide-human calcineurin Al subunit 11 and polynucleotide for coding it |
| 11/07/2001 | CN1320695A Polypeptide-human phosphatidase 12 and polynucleotide for coding it |
| 11/07/2001 | CN1320694A Polypeptide-human YSK1 protein kinase 9 and polynucleotide for coding it |
| 11/07/2001 | CN1320692A Polypeptide-human YSK1 protein kinase 10 and polynucleotide for coding it |
| 11/07/2001 | CN1320691A Polypeptide-human nucleotide reductase 9 and polynucleotide for coding it |
| 11/07/2001 | CN1320690A Polypeptide-human malate dehydrogenase MDH1-22 and polynucleotide for coding it |
| 11/07/2001 | CN1320689A Expression system using autotomy of fusion protein, and reduced polypeptide |
| 11/07/2001 | CN1320641A Polypeptide-human HS1 protein 16 and polynucleotide for coding it |
| 11/07/2001 | CN1320639A Polypeptide-human protein 9 containing characteristic sequence fragment of ribosomal protein L19 and polynucleotide for coding it |
| 11/07/2001 | CN1320637A Polypeptide-human somatotropic hormone 11 and polynucleotide for coding it |
| 11/07/2001 | CN1320636A Polypeptide-human protein 9 containing porin characteristic sequence fragment and polynucleotide for coding it |
| 11/07/2001 | CN1320630A Polypeptide-human nucleolar phosphoprotein 13 and polynucleotide for coding it |
| 11/07/2001 | CN1320626A Polypeptide-human renal cancer RAGE4 antigen 25 and polynucleotide for coding it |
| 11/07/2001 | CN1320624A Polypeptide-human Pax protein 9.9 and polynucleotide for coding it |
| 11/07/2001 | CN1320623A Polypeptide-human protein 11 conservative domain containing G protein coupled receptor and polynucleotide for coding it |
| 11/07/2001 | CN1320622A Polypeptide-human beta-globulin regulatory factor 10 and polynucleotide for coding it |
| 11/07/2001 | CN1320619A Polypeptide-human gap junction protein 9 and polynucleotide for coding it |
| 11/07/2001 | CN1320618A Polypeptide-human Pax protein 12.5 and polynucleotide for coding it |
| 11/07/2001 | CN1320617A Polypeptide-human Pax protein 14 and polynucleotide for coding it |
| 11/07/2001 | CN1320616A Polypeptide-human Pax protein 17 and polynucleotide for coding it |
| 11/07/2001 | CN1320615A Polypeptide-human Pax protein 16 and polynucleotide for coding it |
| 11/07/2001 | CN1320614A Polypeptide-human translation initiation factor accessory factor 81 and polynucleotide for coding it |
| 11/07/2001 | CN1320613A Polypeptide-human ribosome S7 protein 14 and polynucleotide for coding it |
| 11/07/2001 | CN1320611A Polypeptide-cytokine receptor 15 and polynucleotide for coding it |
| 11/07/2001 | CN1320610A Polypeptide-G-beta similar protein 29 and polynucleotide for coding it |
| 11/07/2001 | CN1320608A Polypeptide-laminin 16 and polynucleotide for coding it |
| 11/07/2001 | CN1320607A Polypeptide-laminin 19 and polynucleotide for coding it |
| 11/07/2001 | CN1320426A Compound for treatment of female sexual dysfuction |
| 11/07/2001 | CN1074458C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 11/06/2001 | US6313345 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 11/06/2001 | US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment |
| 11/06/2001 | US6313280 Suppresses brachyury-mediated transcription activation; hybrid screening assays; zinc finger domains; genetic engineering and expression |
| 11/06/2001 | US6313277 Breast cancer resistance protein (BCRP) and the DNA which encodes it |
| 11/06/2001 | US6313272 Nucleotide sequence coding geneticaly engineered protein; for treatment of autoimmune diseases |
| 11/06/2001 | US6313271 OCT-3 polypeptides |
| 11/06/2001 | US6313270 DbpB |
| 11/06/2001 | US6313269 Tumor necrosis factor related receptor, TR6 |
| 11/06/2001 | US6313266 Amino acid sequence of polypeptide which binds histone h1; diagnosis, treatment, and prevention of cancer, autoimmune disorders, and alzheimer's disease; anticarcinogenic agents |
| 11/06/2001 | US6313265 Protein associated with neuronal projections; for use in treatment of nervous system injuries; for use in nervous system regeneration |
| 11/06/2001 | US6313264 Effector proteins of Rapamycin |
| 11/06/2001 | US6313146 Calcium receptor-active molecules |
| 11/06/2001 | US6313140 Method of treatment using certain growth-hormone secret agogues |
| 11/06/2001 | US6313109 Prenyl transferase inhibitors |
| 11/06/2001 | US6313103 Pectic substance as a growth factor stabilizer |
| 11/06/2001 | US6313102 Stabilized dry composition comprising therapeutic agent susceptible to maillard reaction, further comprising reducing carbohydrate as stabilizer for therapeutic agent and inhibitor of maillard reaction |
| 11/06/2001 | US6313098 Treating affective disorder characterized by alterations in psychometric variables as sadness, carbohydrate craving or social withdrawal by administering leptin, leptin analog, leptin fragment, leptin fusion protein or leptin |
| 11/06/2001 | US6313097 Treatment or prophylaxis of migraine or cluster headaches, non-insulin-dependent diabetes mellitus, inflammation, allergic rhinitis, asthma, morphine tolerance, menopausal hot flashes, diseases characterized by excessive vasodilatation |
| 11/06/2001 | US6313096 Inhibitors of trypsin-like enzymes |
| 11/06/2001 | US6313095 Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain |
| 11/06/2001 | US6313093 Applying pharmaceutical composition comprising insulin to upper third of nasal cavity of mammal, wherein insulin is absorbed through nasal mucosa and transported to brain of mammal |
| 11/06/2001 | US6313092 Method for increasing the electrotransport flux of polypeptides |
| 11/06/2001 | US6313091 Pharmaceutical compositions containing TSG-6 for treating inflammatory diseases and cancer-related pathologies and method |
| 11/06/2001 | US6313090 Methods for treating parasitic infection using thiopeptides |
| 11/06/2001 | US6313089 Complexes of apolipoprotein E and ciliary neurotrophic factor (CNTF) and methods of use |
| 11/06/2001 | US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers |
| 11/06/2001 | US6312957 Genetic modification of primate hemopoietic repopulating stem cells |
| 11/06/2001 | US6312947 Nucleotide sequences coding nematode polypeptide; for use in prevention of apoptosis; for use in treating viral and parasitic infections |
| 11/06/2001 | US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases |
| 11/06/2001 | US6312937 Amino acid sequence which encodes a tumor necrosis factor-alpha converting enzyme-like protein and a matrilysin-like protein; diagnosis of cancer; anticarcinogenic agents |
| 11/06/2001 | US6312929 Compositions and methods enabling a totally internally controlled amplification reaction |
| 11/06/2001 | US6312924 Nucleotide sequences coding polypeptides for use in the treatment and diagnosis of autoimmune diseases, cancers and infections |
| 11/06/2001 | US6312923 Method for expression of heterologous proteins in yeast |
| 11/06/2001 | US6312921 Nucleotide sequences which code preferential polyeptides; for use in diagnosis and treatment of tumors |
| 11/06/2001 | US6312916 Mutant polypeptide; for use in reduction of inteference associated with immunoassays |
| 11/06/2001 | US6312909 Compositions and methods for the diagnosis prevention and treatment of tumor progression |
| 11/06/2001 | US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals |
| 11/06/2001 | US6312900 For modulating metastasis of malignant tumors via modulation of activating protein 1 |
| 11/06/2001 | US6312899 A polynucleotide probe for the detection and diagnositic staging of lymphocyte differentiation |
| 11/06/2001 | US6312895 A method for detecting binding proteins by forming hybridization complexes as an indicator of the presence of the polynucleotide encoding the binding protein |
| 11/06/2001 | US6312734 Forming an oxidized glutatione complex with platinum or palladium |
| 11/06/2001 | US6312721 Drugs with carriers of esters of triglycerol with fatty acid and partial esters of decaglycerol and fatty acids |
| 11/06/2001 | US6312720 Liposomal recombinant human superoxide-dismutase for the treatment of peyronie's disease |
| 11/06/2001 | US6312718 Liposomal composition, b-cell malignancy antigen and lipids |
| 11/06/2001 | US6312711 Vehicles for food and drugs, stress proteins, sequential epitopes of antigen structure |
| 11/06/2001 | US6312708 Botulinum toxin implant |
| 11/06/2001 | US6312700 Fusion proteins and receptors |